Functional brain training alleviates chemotherapy-induced peripheral nerve damage in cancer survivor

March 03, 2017

A type of functional brain training known as neurofeedback shows promise in reducing symptoms of chemotherapy-induced nerve damage, or neuropathy, in cancer survivors, according to a study by researchers at The University of Texas MD Anderson Cancer Center. The pilot study, published in the journal Cancer, is the largest, to date, to determine the benefits of neurofeedback in cancer survivors.

Chronic chemotherapy-induced peripheral neuropathy (CIPN) is caused by damage to the nerves that control sensation and movement in arms and legs. CIPN is estimated to affect between 71 and 96 percent of patients one month after chemotherapy treatment, with symptoms including pain, burning, tingling and loss of feeling, explained Sarah Prinsloo, Ph.D., assistant professor of Palliative, Rehabilitation, and Integrative Medicine.

"There is currently only one approved medication to treat CIPN and it has associated muscle aches and nausea," said Prinsloo, lead investigator of the study. "Neurofeedback has no known negative side effects, can be used in combinations with other treatments and is reasonably cost effective."

In previous research, Prinsloo identified the location of brain activity that contributes to the physical and emotional aspects of chronic pain. By targeting brain areas that are active during pain episodes, neurofeedback teaches participants to understand pain signals differently.

The researchers developed training protocols which allow patients to retrain their own brain activity through electroencephalogram (EEG) neurofeedback. The EEG interface tracks and records brain wave patterns by attaching small metal discs with thin wires to the scalp. Brain wave signals are sent to a computer and displayed for participants, who receive visual and auditory rewards when making targeted adjustments to brain wave patterns.

The randomized, controlled study enrolled 71 MD Anderson patients of all cancer types; all were at least three months post-chemotherapy treatment and reported more than a three on the National Cancer Institute's neuropathy rating scale. The Brief Pain Inventory (BPI) assessment was used to measure the severity of pain and impact on daily functioning. The BPI worst-pain item was the primary outcome.

Patients in the neurofeedback group attended 20 sessions in which they played a computer game that trained them to modify brain wave activity in the targeted area. Over time, participants learned to manipulate brain activity without an immediate reward from the game. The control group was offered the neurofeedback intervention at the conclusion of the study.

After completing treatment, participants repeated EEG measurements and pain assessments to determine changes in pain perception, cancer related symptoms, quality of life and brain wave activity in targeted areas.

At the beginning of the study, groups reported no significant differences in neuropathy symptoms. At the completion of the study, patients in the neurofeedback group reported significantly reduced BPI scores for worst pain, activity interference, numbness, tingling, and unpleasantness, compared to the control group.

Patients with CIPN also exhibited specific and predictable EEG signatures in the targeted brain regions that changed with neurofeedback.

"We observed clinically and statistically significant reductions in peripheral neuropathy following neurofeedback techniques," said Prinsloo. "This research suggests that neurofeedback may be a valuable approach to reduce neuropathy symptoms and their impact on daily activities."

One limitation of the study was the lack of a placebo group. Researchers studied areas of the brain that are active during placebo pain relief and determined that, although the placebo effect could be a factor, it was not the only factor leading to symptom improvement, said Prinsloo. Additionally, most study participants were female and breast cancer survivors. Future research will need to include a broader participant base to determine if the findings apply across the general population.

Current approved drugs for CIPN have known of side effects. The lack of adverse effects using neurofeedback is particularly important to emphasize for cancer patients with existing comorbidities.
-end-
In addition to Prinsloo, MD Anderson authors include: Diane Novy, Ph.D., and Larry Driver, M.D., both of Pain Medicine; Lois Ramondetta, M.D., Gynecologic Oncology and Reproductive Medicine; Cathy Eng, M.D., Gastrointestinal Medical Oncology; Jennifer McQuade, M.D., Cancer Medicine; and Gabriel Lopez, M.D., and Lorenzo Cohen, Ph.D., both of Palliative, Rehabilitation and Integrative Medicine. An additional author is Randall Lyle, Ph.D., Mount Mercy University.

This study was funded by the American Cancer Society (PF-11-169-01-PCSM), the Rising Tide Foundation, the Hille Foundation and the National Center for Complementary and Integrative Health (1K01AT008485-01).

University of Texas M. D. Anderson Cancer Center

Related Brain Activity Articles from Brightsurf:

Inhibiting epileptic activity in the brain
A new study shows that a protein -- called DUSP4 -- was increased in healthy brain tissue directly adjacent to epileptic tissue.

What is your attitude towards a humanoid robot? Your brain activity can tell us!
Researchers at IIT-Istituto Italiano di Tecnologia in Italy found that people's bias towards robots, that is, attributing them intentionality or considering them as 'mindless things', can be correlated with distinct brain activity patterns.

Using personal frequency to control brain activity
Individual frequency can be used to specifically influence certain areas of the brain and thus the abilities processed in them - solely by electrical stimulation on the scalp, without any surgical intervention.

Rats' brain activity reveals their alcohol preference
The brain's response to alcohol varies based on individual preferences, according to new research in rats published in eNeuro.

Studies of brain activity aren't as useful as scientists thought
Hundreds of published studies over the last decade have claimed it's possible to predict an individual's patterns of thoughts and feelings by scanning their brain in an MRI machine as they perform some mental tasks.

A child's brain activity reveals their memory ability
A child's unique brain activity reveals how good their memories are, according to research recently published in JNeurosci.

How dopamine drives brain activity
Using a specialized magnetic resonance imaging (MRI) sensor that can track dopamine levels, MIT neuroscientists have discovered how dopamine released deep within the brain influences distant brain regions.

Brain activity intensity drives need for sleep
The intensity of brain activity during the day, notwithstanding how long we've been awake, appears to increase our need for sleep, according to a new UCL study in zebrafish, published in Neuron.

Do babies like yawning? Evidence from brain activity
Contagious yawning is observed in many mammals, but there is no such report in human babies.

Understanding brain activity when you name what you see
Using complex statistical methods and fast measurement techniques, researchers found how the brain network comes up with the right word and enables us to say it.

Read More: Brain Activity News and Brain Activity Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.